A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits
A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits
复制标题
DOI:
10.1097/00006231-200011000-00010
复制
发表时间:
2000-11-01
影响因子:
1.5
通讯作者:
Corstens, FHM
中科院分区:
文献类型:
--
作者:
Brouwers, AH;Laverman, P;Corstens, FHM
In a search for a rapid and accurate imaging agent for scintigraphic detection of infection and inflammation, an LTB4 receptor antagonist, Tc-99(m)-RP517, which contains the hydrazino nicotinamide moiety, has been del eloped recently. To study the in vivo behaviour of Tc-99(m)-RP517, rabbits with Escherichia coli infection were injected intravenously with Tc-99(m)-RP517. Gamma camera images were obtained and ex vivo bio-distribution was determined at several hours post-injection (p.i.). In a separate set of rabbits the choledochal duct was cannulated to quantitatively monitor the hepatobiliary clearance of the radiopharmaceutical. The receptor binding fraction of the radiolabelled RP517 exceeded 70%. Accumulation of Tc-99(m)-RP517 in the abscess was visualized as early as Ih p.i. Due to rapid blood clearance (t1/2 alpha =18 +/- 0.6 min, t1/2 beta =6.5 +/- 0.4 h) and high abscess uptake, the abscess-to-muscle ratios increased with time from 7.0 +/- 2.3 at 1 h p.i. to 44.3 +/- 4.6 at 20 h p.i. The agent mainly cleared via the hepatobiliary route: 50% of the radiolabel was recovered in the small bowel at 1 h p.i., whereas 85% was found in cecum and sigmoid at 20 h p.i. In conclusion, Tc-99(m)-RP517 rapidly visualized E. coli abscesses in rabbits. The agent rapidly cleared from the blood, mainly via the hepatobiliary route. High abscess-to-background ratios were achieved. The accumulation in the intestines could limit the applicability of this agent for detecting infectious processes in the abdominal area. The development of a more hydrophilic analogue of Tc-99(m)-RP517 could improve the clinical applicability of this agent. ((C) 2000 Lippincott Williams & Wilkins).